Literature DB >> 20848109

Experimental studies investigating the pathophysiology of nephrogenic systemic fibrosis; what did we learn so far?

Sameh K Morcos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20848109     DOI： 10.1007/s00330-010-1951-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN： 0938-7994            Impact factor:   5.315


× No keyword cloud information.
  25 in total

1.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Authors:  Thomas Grobner
Journal:  Nephrol Dial Transplant       Date:  2006-01-23       Impact factor: 5.992

2.  Human erythrocyte transglutaminase: purification and preliminary characterisation.

Authors:  M Signorini; F Bortolotti; L Poltronieri; C M Bergamini
Journal:  Biol Chem Hoppe Seyler       Date:  1988-04

3.  Effects of gadolinium-based magnetic resonance imaging contrast agents on human skin in organ culture and human skin fibroblasts.

Authors:  James Varani; Marissa DaSilva; Roscoe L Warner; Monica O'Brien Deming; Adam G Barron; Kent J Johnson; Richard D Swartz
Journal:  Invest Radiol       Date:  2009-02       Impact factor: 6.016

4.  Biodistribution of GdCl3 and Gd-DTPA and their influence on proton magnetic relaxation in rat tissues.

Authors:  J L Barnhart; N Kuhnert; D A Bakan; R N Berk
Journal:  Magn Reson Imaging       Date:  1987       Impact factor: 2.546

5.  Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review.

Authors:  Marc Port; Jean-Marc Idée; Christelle Medina; Caroline Robic; Monique Sabatou; Claire Corot
Journal:  Biometals       Date:  2008-03-15       Impact factor: 2.949

6.  Nephrogenic systemic fibrosis in rats treated with erythropoietin and intravenous iron.

Authors:  Thomas A Hope; Whitney A High; Philip E Leboit; Bundit Chaopathomkul; Victor S Rogut; Robert J Herfkens; Robert C Brasch
Journal:  Radiology       Date:  2009-09-29       Impact factor: 11.105

7.  Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions.

Authors:  Martin A Sieber; Philipp Lengsfeld; Thomas Frenzel; Sven Golfier; Heribert Schmitt-Willich; Fred Siegmund; Jakob Walter; Hanns-Joachim Weinmann; Hubertus Pietsch
Journal:  Eur Radiol       Date:  2008-06-11       Impact factor: 5.315

Review 8.  Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.

Authors:  Dale R Broome
Journal:  Eur J Radiol       Date:  2008-03-26       Impact factor: 3.528

9.  Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis.

Authors:  M Edward; J A Quinn; S Mukherjee; M-B V Jensen; A G Jardine; P B Mark; A D Burden
Journal:  J Pathol       Date:  2008-04       Impact factor: 7.996

10.  Long-term retention of gadolinium in the skin of rodents following the administration of gadolinium-based contrast agents.

Authors:  Hubertus Pietsch; Philipp Lengsfeld; Gregor Jost; Thomas Frenzel; Joachim Hütter; Martin A Sieber
Journal:  Eur Radiol       Date:  2009-01-24       Impact factor: 5.315
View more
  6 in total

Review 1.  Recent hot topics in contrast media.

Authors:  Henrik S Thomsen
Journal:  Eur Radiol       Date:  2010-12-07       Impact factor: 5.315

2.  Total gadolinium tissue deposition and skin structural findings following the administration of structurally different gadolinium chelates in healthy and ovariectomized female rats.

Authors:  Yì-Xiáng J Wáng; Joseph Schroeder; Heiko Siegmund; Jean-Marc Idée; Nathalie Fretellier; Gaëlle Jestin-Mayer; Cecile Factor; Min Deng; Wei Kang; Sameh K Morcos
Journal:  Quant Imaging Med Surg       Date:  2015-08

3.  Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).

Authors:  Tomohiro Sato; Tsutomu Tamada; Shigeru Watanabe; Hirotake Nishimura; Akihiko Kanki; Yasufumi Noda; Atsushi Higaki; Akira Yamamoto; Katsuyoshi Ito
Journal:  Radiol Med       Date:  2015-01-09       Impact factor: 3.469

Review 4.  X-ray-computed tomography contrast agents.

Authors:  Hrvoje Lusic; Mark W Grinstaff
Journal:  Chem Rev       Date:  2012-12-05       Impact factor: 60.622

Review 5.  Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.

Authors:  Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Marie-France Bellin; Michele Bertolotto; Georg Bongartz; Olivier Clement; Peter Leander; Gertraud Heinz-Peer; Peter Reimer; Fulvio Stacul; Aart van der Molen; Judith A W Webb
Journal:  Eur Radiol       Date:  2012-08-04       Impact factor: 5.315

Review 6.  Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance.

Authors:  Theresa Reiter; Oliver Ritter; Martin R Prince; Peter Nordbeck; Christoph Wanner; Eike Nagel; Wolfgang Rudolf Bauer
Journal:  J Cardiovasc Magn Reson       Date:  2012-05-20       Impact factor: 5.364
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.